Plain-English translation of NCT07470593 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
People with type 1 diabetes who receive pancreatic islet transplants often see dramatic improvements in blood sugar control. However, over time, these transplanted cells gradually stop working as well as they used to. Right now, doctors don't have a reliable way to catch this decline early. This study uses a continuous glucose monitor (a small device that tracks your blood sugar throughout the day) to see if certain patterns can help identify when the transplanted cells are starting to fail.
Transplanted pancreatic islets work wonderfully at first, but their effectiveness fades over time. Without an early warning system, doctors and patients don't know when function is declining until blood sugar control noticeably worsens. This study aims to find a simple, non-invasive way to catch problems early so patients can get help before their blood sugar becomes difficult to manage again.
You likely qualify if…
You likely don't qualify if…
You would wear a continuous glucose monitor—a small sensor on your skin that tracks your blood sugar levels throughout the day and night. The study team would collect data from your glucose monitor over time to look for patterns that might suggest your transplanted islet cells are beginning to lose function. This is an observational study, meaning the researchers are watching and measuring rather than testing a new medication or procedure; you would continue your regular diabetes care as usual.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
France